Loading...

Renalytix Plc

RNLX•NASDAQ
Healthcare
Medical - Healthcare Information Services
$0.21
$0.01(5.66%)

Renalytix Plc (RNLX) Stock Overview

Explore Renalytix Plc’s financial performance, market position, analyst ratings, and future outlook.

Meyka AI Score

B

Score: 66.1/100

Key Financials

Market Cap22.5M
P/E Ratio-0.56
EPS (TTM)$-0.62
ROE1.94%
Fundamental Analysis

AI Price Forecasts

1 WeekN/A
1 MonthN/A
3 MonthsN/A
1 Year Target$0.07

RNLX Stock Analysis & Investment Overview

Our comprehensive AI-powered analysis of Renalytix Plc (RNLX) provides investors with deep insights into the stock's performance, growth potential, and market positioning. With a Meyka AI Score of B, this stock demonstrates moderate investment characteristics based on our advanced machine learning models.

Our forecasting models predict significant price movements, with a 12-month target of $0.07.

Key financial metrics showcase the company's fundamental strength, including a P/E ratio of -0.56 and a market capitalization of 22.5M. These metrics, combined with our AI analysis, provide a comprehensive view for both institutional and retail investors.

1-Day Change
N/A
5-Day Change
23.86%
1-Month Change
5.66%
3-Month Change
-44.03%
6-Month Change
-69.98%
Year-to-Date (YTD) Change
-51.27%
1-Year Change
-80.09%
3-Year Change
-99.09%
5-Year Change
-98.47%
All-Time (Max) Change
-98.47%

Contact Information

https://renalytix.com
646 397 3970
1460 Broadway, New York City, NY, 10036

Company Facts

102 Employees
IPO DateJul 17, 2020
CountryUS

Frequently Asked Questions

;